Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy

Neurobiol Dis. 2021 Jun:153:105332. doi: 10.1016/j.nbd.2021.105332. Epub 2021 Mar 17.

Abstract

Pathological aggregates of alpha-synuclein in peripheral dermal nerve fibers can be detected in patients with idiopathic Parkinson's disease and multiple system atrophy. This study combines skin biopsy staining for p-alpha-synuclein depositions and radionuclide imaging of the heart with [123I]-metaiodobenzylguanidine to explore peripheral denervation in both diseases. To this purpose, 42 patients with a clinical diagnosis of Parkinson's disease or multiple system atrophy were enrolled. All patients underwent a standardized clinical work-up including neurological evaluation, neurography, and blood samples. Skin biopsies were obtained from the distal and proximal leg, back, and neck for immunofluorescence double labeling with anti-p-alpha-synuclein and anti-PGP9.5. All patients underwent myocardial [123I]-metaiodobenzylguanidine scintigraphy. Dermal p-alpha-synuclein was observed in 47.6% of Parkinson's disease patients and was mainly found in autonomic structures. 81.0% of multiple system atrophy patients had deposits with most of cases in somatosensory fibers. The [123I]-metaiodobenzylguanidine heart-to-mediastinum ratio was lower in Parkinson's disease than in multiple system atrophy patients (1.94 ± 0.63 vs. 2.91 ± 0.96; p < 0.0001). Irrespective of the diagnosis, uptake was lower in patients with than without p-alpha-synuclein in autonomic structures (1.42 ± 0.51 vs. 2.74 ± 0.83; p < 0.0001). Rare cases of Parkinson's disease with p-alpha-synuclein in somatosensory fibers and multiple system atrophy patients with deposits in autonomic structures or both fiber types presented with clinically overlapping features. In conclusion, this study suggests that alpha-synuclein contributes to peripheral neurodegeneration and mediates the impairment of cardiac sympathetic neurons in patients with synucleinopathies. Furthermore, it indicates that Parkinson's disease and multiple system atrophy share pathophysiologic mechanisms of peripheral nervous system dysfunction with a clinical overlap.

Keywords: MIBG scintigraphy; Multiple system atrophy; Parkinson's disease; Peripheral nervous system; Skin biopsy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Iodobenzylguanidine
  • Adult
  • Aged
  • Autonomic Fibers, Postganglionic / pathology*
  • Female
  • Heart / diagnostic imaging*
  • Heart / innervation
  • Humans
  • Male
  • Middle Aged
  • Multiple System Atrophy / diagnostic imaging
  • Multiple System Atrophy / metabolism
  • Multiple System Atrophy / pathology*
  • Nerve Fibers / metabolism
  • Nerve Fibers / pathology
  • Neural Conduction
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / metabolism
  • Parkinson Disease / pathology*
  • Peripheral Nervous System / diagnostic imaging
  • Peripheral Nervous System / metabolism
  • Peripheral Nervous System / pathology*
  • Phosphorylation
  • Radionuclide Imaging
  • Radiopharmaceuticals
  • Skin / innervation
  • Skin / pathology*
  • alpha-Synuclein / metabolism*

Substances

  • Radiopharmaceuticals
  • SNCA protein, human
  • alpha-Synuclein
  • 3-Iodobenzylguanidine